Lipidomics Biomarkers of Diet-Induced Hyperlipidemia and Its Treatment with Poria cocos

Journal of Agricultural and Food Chemistry

Volumn 64, Issue 4, 2016, Pages 969-979

  Miao, Hua ^a,b   Zhao, Yu Hui ^a   Vaziri, Nosratola D ^b   Tang, Dan Dan ^a   Chen, Hua ^a   Chen, Han ^a   Khazaeli, Mahyar ^b   Tarbiat Boldaji, Mehrdokht ^b   Hatami, Leili ^b   Zhao, Ying Yong ^a,b  

^a NORTHWEST UNIVERSITY   (China)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

fatty acid metabolism; hyperlipidemia; lipidomics; mass spectrometry; Poria cocos; ultraperformance liquid chromatography

Indexed keywords

BIOCHEMISTRY; CHOLESTEROL; ENZYME INHIBITION; LIPIDS; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; METABOLISM; METABOLITES; PALMITIC ACID; PHYSIOLOGY; RATS;

FATTY ACID METABOLISM; HYPERLIPIDEMIA; LIPIDOMICS; PORIA COCOS; ULTRAPERFORMANCE LIQUID CHROMATOGRAPHY;

FATTY ACIDS;

ANTILIPEMIC AGENT; BIOLOGICAL MARKER; CHOLESTEROL; LOW DENSITY LIPOPROTEIN; TRIACYLGLYCEROL;

ADVERSE EFFECTS; ANIMAL; BLOOD; CHEMISTRY; HUMAN; HYPERLIPIDEMIAS; LIPID DIET; MALE; PORIA; RAT; SPRAGUE DAWLEY RAT;

ANIMALS; BIOMARKERS; CHOLESTEROL; DIET, HIGH-FAT; HUMANS; HYPERLIPIDEMIAS; HYPOLIPIDEMIC AGENTS; LIPOPROTEINS, LDL; MALE; PORIA; RATS; RATS, SPRAGUE-DAWLEY; TRIGLYCERIDES;

EID: 84956950829     PISSN: 00218561     EISSN: 15205118     Source Type: Journal    
DOI: 10.1021/acs.jafc.5b05350     Document Type: Article

References (47)

1. LaRosa, J. C. Prevention and treatment of coronary heart disease: who benefits? Circulation 2001, 104, 1688-1692 10.1161/hc3901.096665
2. Alwaili, K.; Alrasadi, K.; Awan, Z.; Genest, J. Approach to the diagnosis and management of lipoprotein disorders Curr. Opin. Endocrinol., Diabetes Obes. 2009, 16, 132-140 10.1097/MED.0b013e328329135a
3. Wilkinson, M. J.; Laffin, L. J.; Davidson, M. H. Overcoming toxicity and side-effects of lipid-lowering therapies Best Pract. Res. Clin. Endocrinol. Metab. 2014, 28, 439-452 10.1016/j.beem.2014.01.006
4. Harvey, A. L.; Edrada-Ebel, R.; Quinn, R. J. The re-emergence of natural products for drug discovery in the genomics era Nat. Rev. Drug Discovery 2015, 14, 111-129 10.1038/nrd4510
5. Lindner, D. L.; Banik, M. T. Molecular phylogeny of Laetiporus and other brown rot polypore genera in North America Mycologia 2008, 100, 417-430 10.3852/07-124R2
6. Wang, Y. Z.; Zhang, J.; Zhao, Y. L.; Li, T.; Shen, T.; Li, J. Q.; Li, W. Y.; Liu, H. G. Mycology, cultivation, traditional uses, phytochemistry and pharmacology of Wolfiporia cocos (Schwein.) Ryvarden et Gilb.: a review J. Ethnopharmacol. 2013, 147, 265-276 10.1016/j.jep.2013.03.027
7. E J. Pharm. Biomed. Anal. 2013, 81-82, 202-209 10.1016/j.jpba.2013.03.028
8. Zhao, Y. Y.; Li, H. T.; Feng, Y. L.; Bai, X.; Lin, R. C. Urinary metabonomic study of the surface layer of Poria cocos as an effective treatment for chronic renal injury in rats J. Ethnopharmacol. 2013, 148, 403-410 10.1016/j.jep.2013.04.018
9. Lu, Y. T.; Kuan, Y. C.; Chang, H. H.; Sheu, F. Molecular cloning of a Poria cocos protein that activates Th1 immune response and allays Th2 cytokine and IgE production in a murine atopic dermatitis model J. Agric. Food Chem. 2014, 62, 2861-2871 10.1021/jf405507e
10. Han, X.; Gross, R. W. Global analyses of cellular lipidomes directly from crude extracts of biological samples by ESI mass spectrometry: a bridge to lipidomics J. Lipid Res. 2003, 44, 1071-1079 10.1194/jlr.R300004-JLR200
11. Zhao, Y. Y.; Cheng, X. L.; Lin, R. C.; Wei, F. Lipidomics applications for disease biomarker discovery in mammal models Biomarkers Med. 2015, 9, 153-168 10.2217/bmm.14.81
12. Zhao, Y. Y.; Cheng, X. L.; Lin, R. C. Lipidomics applications for discovering biomarkers of diseases in clinical chemistry Int. Rev. Cell Mol. Biol. 2014, 313, 1-26 10.1016/B978-0-12-800177-6.00001-3
13. Zhao, Y. Y.; Miao, H.; Cheng, X. L.; Wei, F. Lipidomics: Novel insight into the biochemical mechanism of lipid metabolism and dysregulation-associated disease Chem.-Biol. Interact. 2015, 240, 220-238 10.1016/j.cbi.2015.09.005
14. Kwan, H. Y.; Hu, Y. M.; Chan, C. L.; Cao, H. H.; Cheng, C. Y.; Pan, S. Y.; Tse, K. W.; Wu, Y. C.; Yu, Z. L.; Fong, W. F. Lipidomics identification of metabolic biomarkers in chemically induced hypertriglyceridemic mice J. Proteome Res. 2013, 12, 1387-1398 10.1021/pr3010327
15. Yin, W.; Carballo-Jane, E.; McLaren, D. G.; Mendoza, V. H.; Gagen, K.; Geoghagen, N. S.; McNamara, L. A.; Gorski, J. N.; Eiermann, G. J.; Petrov, A.; Wolff, M.; Tong, X.; Wilsie, L. C.; Akiyama, T. E.; Chen, J.; Thankappan, A.; Xue, J.; Ping, X.; Andrews, G.; Wickham, L. A.; Gai, C. L.; Trinh, T.; Kulick, A. A.; Donnelly, M. J.; Voronin, G. O.; Rosa, R.; Cumiskey, A. M.; Bekkari, K.; Mitnaul, L. J.; Puig, O.; Chen, F.; Raubertas, R.; Wong, P. H.; Hansen, B. C.; Koblan, K. S.; Roddy, T. P.; Hubbard, B. K.; Strack, A. M. Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia J. Lipid Res. 2012, 53, 51-65 10.1194/jlr.M019927
16. Chen, F.; Maridakis, V.; O'Neill, E. A.; Hubbard, B. K.; Strack, A.; Beals, C.; Herman, G. A.; Wong, P. The effects of simvastatin treatment on plasma lipid-related biomarkers in men with dyslipidaemia Biomarkers 2011, 16, 321-333 10.3109/1354750X.2011.561367
17. Miao, H.; Li, M. H.; Zhang, X.; Yuan, S. J.; Ho, C. C.; Zhao, Y. Y. The antihyperlipidemic effect of Fu-Ling-Pi is associated with abnormal fatty acid metabolism as assessed by UPLC-HDMS-based lipidomics RSC Adv. 2015, 5, 64208-64219 10.1039/C5RA09766E
18. Wu, S.; Chen, S.; Dong, X.; Tan, G.; Li, W.; Lou, Z.; Zhu, Z.; Chai, Y. Lipidomic profiling reveals significant alterations in lipid biochemistry in hypothyroid rat cerebellum and the therapeutic effects of Sini decoction J. Ethnopharmacol. 2015, 159, 262-273 10.1016/j.jep.2014.11.033
19. Cai, Y.; Gao, Y.; Tan, G.; Wu, S.; Dong, X.; Lou, Z.; Zhu, Z.; Chai, Y. Myocardial lipidomics profiling delineate the toxicity of traditional Chinese medicine Aconiti Lateralis radix praeparata J. Ethnopharmacol. 2013, 147, 349-356 10.1016/j.jep.2013.03.017
20. Zhao, Y. Y.; Wu, S. P.; Liu, S.; Zhang, Y.; Lin, R. C. Ultra-performance liquid chromatography-mass spectrometry as a sensitive and powerful technology in lipidomic applications Chem.-Biol. Interact. 2014, 220, 181-192 10.1016/j.cbi.2014.06.029
21. E application in disease biomarker discovery: the discoveries in proteomics to metabolomics Chem.-Biol. Interact. 2014, 215, 7-16 10.1016/j.cbi.2014.02.014
22. Miao, H.; Chen, H.; Zhang, X.; Yin, L.; Chen, D. Q.; Cheng, X. L.; Bai, X.; Wei, F. Urinary metabolomics on the biochemical profiles in diet-induced hyperlipidemia rat using ultraperformance liquid chromatography coupled with quadrupole time-of-flight SYNAPT high-definition mass spectrometry J. Anal. Methods Chem. 2014, 2014, 184162 10.1155/2014/184162
23. Miao, H.; Chen, H.; Pei, S.; Bai, X.; Vaziri, N. D.; Zhao, Y. Y. Plasma lipidomics reveal profound perturbation of glycerophospholipids, fatty acids, and sphingolipids in diet-induced hyperlipidemia Chem.-Biol. Interact. 2015, 228, 79-87 10.1016/j.cbi.2015.01.023
24. E data collection technique Biomarkers 2012, 17, 721-729 10.3109/1354750X.2012.724450
25. Fahy, E.; Subramaniam, S.; Brown, H. A.; Glass, C. K.; Merrill, A. H., Jr.; Murphy, R. C.; Raetz, C. R.; Russell, D. W.; Seyama, Y.; Shaw, W.; Shimizu, T.; Spener, F.; van Meer, G.; VanNieuwenhze, M. S.; White, S. H.; Witztum, J. L.; Dennis, E. A. A comprehensive classification system for lipids J. Lipid Res. 2005, 46, 839-862 10.1194/jlr.E400004-JLR200
26. Chong, W. P.; Goh, L. T.; Reddy, S. G.; Yusufi, F. N.; Lee, D. Y.; Wong, N. S.; Heng, C. K.; Yap, M. G.; Ho, Y. S. Metabolomics profiling of extracellular metabolites in recombinant Chinese hamster ovary fed-batch culture Rapid Commun. Mass Spectrom. 2009, 23, 3763-3771 10.1002/rcm.4328
27. Chen, H.; Miao, H.; Feng, Y. L.; Zhao, Y. Y.; Lin, R. C. Metabolomics in dyslipidemia Adv. Clin. Chem. 2014, 66, 101-119 10.1016/B978-0-12-801401-1.00004-9
28. Zhang, Q.; Wang, G.; A, J.; Ma, B.; Dua, Y.; Zhu, L.; Wu, D. Metabonomic profiling of diet-induced hyperlipidaemia in a rat model Biomarkers 2010, 15, 205-216 10.3109/13547500903419049
29. Bai, D.; Song, J. N. Plasma metabolic biomarkers for syndrome of phlegm and blood stasis in hyperlipidemia and atherosclerosis J. Trad. Chin. Med. 2012, 32, 578-583 10.1016/S0254-6272(13)60074-6
30. Zhang, Q.; Wang, G. J.; A, J. Y.; Wu, D.; Zhu, L. L.; Ma, B.; Du, Y. Application of GC/MS-based metabonomic profiling in studying the lipid-regulating effects of Ginkgo biloba extract on diet-induced hyperlipidemia in rats Acta Pharmacol. Sin. 2009, 30, 1674-1687 10.1038/aps.2009.173
31. Ooga, T.; Sato, H.; Nagashima, A.; Sasaki, K.; Tomita, M.; Soga, T.; Ohashi, Y. Metabolomic anatomy of an animal model revealing homeostatic imbalances in dyslipidaemia Mol. BioSyst. 2011, 7, 1217-1223 10.1039/c0mb00141d
32. Roman, L. J.; Palmer, C. N. A.; Clark, J. E.; Masters, B. S. S. Expression of rabbit cytochromes P-450 which catalyze the ω-hydroxylation of arachidonic acid, fatty acid and prostaglandins Arch. Biochem. Biophys. 1993, 307, 57-65 10.1006/abbi.1993.1560
33. Liu, Y. T.; Jia, H. M.; Chang, X.; Cheng, W. H.; Zhao, X.; Ding, G.; Zhang, H. W.; Cai, D. Y.; Zou, Z. M. Metabolic pathways involved in Xin-Ke-Shu protecting against myocardial infarction in rats using ultra high-performance liquid chromatography coupled with quadrupole time-of-flight mass spectrometry J. Pharm. Biomed. Anal. 2014, 90, 35-44 10.1016/j.jpba.2013.11.008
34. Zhao, Y. Y.; Feng, Y. L.; Bai, X.; Tan, X. J.; Lin, R. C.; Mei, Q. Ultra performance liquid chromatography-based metabonomic study of therapeutic effect of the surface layer of Poria cocos on adenine-induced chronic kidney disease provides new insight into anti-fibrosis mechanism PLoS One 2013, 8, e59617 10.1371/journal.pone.0059617
35. Tarantino, G.; Colao, A.; Capone, D.; Conca, P.; Tarantino, M.; Grimaldi, E.; Chianese, D.; Finelli, C.; Contaldo, F.; Scopacasa, F.; Savastano, S. Circulating levels of cytochrome C, gamma-glutamyl transferase, triglycerides and unconjugated bilirubin in overweight/obese patients with non-alcoholic fatty liver disease J. Biol. Regul. Homeost. Agents. 2011, 25, 47-56
36. 1H NMR-based metabolomics approach to evaluate the effect of Xue-Fu-Zhu-Yu decoction on hyperlipidemia rats induced by high-fat diet J. Pharm. Biomed. Anal. 2013, 78-79, 202-210 10.1016/j.jpba.2013.02.014
37. Araya, J.; Rodrigo, R.; Videla, L. A.; Thielemann, L.; Orellana, M.; Pettinelli, P.; Poniachik, J. Increase in long-chain polyunsaturated fatty acid n-6/n-3 ratio in relation to hepatic steatosis in patients with non-alcoholic fatty liver disease Clin. Sci. 2004, 106, 635-643 10.1042/CS20030326
38. Wang, M.; Wang, Y.; Zhao, M.; Wang, F.; Zhao, C. Metabolic profiling analysis of fatty acids from hyperlipidemic rats treated with Gynostemma pentaphyllum and atorvastatin based on GC/MS Anal. Methods 2014, 6, 8660-8667 10.1039/C4AY01405G
39. Kleemann, R.; Verschuren, L.; van Erk, M. J.; Nikolsky, Y.; Cnubben, N. H.; Verheij, E. R.; Smilde, A. K.; Hendriks, H. F.; Zadelaar, S.; Smith, G. J.; Kaznacheev, V.; Nikolskaya, T.; Melnikov, A.; Hurt-Camejo, E.; van der Greef, J.; van Ommen, B.; Kooistra, T. Atherosclerosis and liver inflammation induced by increased dietary cholesterol intake: a combined transcriptomics and metabolomics analysis Genome Biol. 2007, 8, R200 10.1186/gb-2007-8-9-r200
40. Toye, A. A.; Dumas, M. E.; Blancher, C.; Rothwell, A. R.; Fearnside, J. F.; Wilder, S. P.; Bihoreau, M. T.; Cloarec, O.; Azzouzi, I.; Young, S.; Barton, R. H.; Holmes, E.; McCarthy, M. I.; Tatoud, R.; Nicholson, J. K.; Scott, J.; Gauguier, D. Subtle metabolic and liver gene transcriptional changes underlie diet-induced fatty liver susceptibility in insulin-resistant mice Diabetologia 2007, 50, 1867-1879 10.1007/s00125-007-0738-5
41. Li, T.; Chiang, J. Y. Bile acid signaling in liver metabolism and diseases J. Lipids 2012, 2012, 754067 10.1155/2012/754067
42. Hofmann, A. F. The continuing importance of bile acids in liver and intestinal disease Arch. Intern. Med. 1999, 159, 2647-2658 10.1001/archinte.159.22.2647
43. Gu, S.; A, J.; Wang, G.; Zha, W.; Yan, B.; Zhang, Y.; Ren, H.; Cao, B.; Liu, L. Metabonomic profiling of liver metabolites by gas chromatography-mass spectrometry and its application to characterizing hyperlipidemia Biomed. Chromatogr. 2010, 24, 245-252 10.1002/bmc.1279
44. Tilvis, R. S.; Miettinen, T. A. Serum plant sterols and their relation to cholesterol absorption Am. J. Clin. Nutr. 1986, 43, 92-97
45. Castro-Perez, J. M.; Roddy, T. P.; Shah, V.; McLaren, D. G.; Wang, S. P.; Jensen, K.; Vreeken, R. J.; Hankemeier, T.; Johns, D. G.; Previs, S. F.; Hubbard, B. K. Identifying static and kinetic lipid phe-notypes by high resolution UPLC-MS: unraveling diet-induced changes in lipid homeostasis by coupling metabolomics and fluxomics J. Proteome Res. 2011, 10, 4281-4290 10.1021/pr200480g
46. Zhang, F.; Jia, Z.; Gao, P.; Kong, H.; Li, X.; Chen, J.; Yang, Q.; Yin, P.; Wang, J.; Lu, X.; Li, F.; Wu, Y.; Xu, G. Metabonomics study of atherosclerosis rats by ultra fast liquid chromatography coupled with ion trap-time of flight mass spectrometry Talanta 2009, 79, 836-844 10.1016/j.talanta.2009.05.010
47. Houten, S. M.; Watanabe, M.; Auwerx, J. Endocrine functions of bile acids EMBO J. 2006, 25, 1419-1425 10.1038/sj.emboj.7601049